Towards TB elimination: how are macro-level factors perceived and addressed in policy initiatives in a high burden country?
Health system
Perception
South Africa
Structural determinants
Tuberculosis
Journal
Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734
Informations de publication
Date de publication:
11 01 2021
11 01 2021
Historique:
received:
03
11
2019
accepted:
17
12
2020
entrez:
12
1
2021
pubmed:
13
1
2021
medline:
29
1
2022
Statut:
epublish
Résumé
Notwithstanding extensive general discussion of the effects of upstream forces on health, there has been limited empirical examination, let alone systematic evidence documenting policy responses to such pathways in the area of tuberculosis (TB) management and control. Our study aimed to gain insight into how macro level drivers of TB are perceived by key stakeholders involved in TB management and control in a high-endemic country, and to assess how such concerns are being addressed in policy initiatives in this setting. South Africa was chosen for this case study due to our team's long-standing collaborations there, its very high burden of TB, and its introduction of a strategic plan to combat this disease. Semi-structured interviews were conducted with 20 key informants who were purposively selected for their knowledge and expertise of TB in South Africa. South Africa's National Strategic Plan for HIV, TB and STIs 2017-2022 was then reviewed to examine how identified themes from the interviews were reflected in this policy document. A history of colonization, the migrant labour system, economic inequality, poor shelter, health system challenges including TB governance, the HIV epidemic, and pertinent socio-cultural factors were all perceived to be major drivers of the epidemic. Although South Africa's current National Strategic Plan makes a firm discursive commitment to addressing the structural or macro-level drivers of TB, our analysis revealed that this commitment was not clearly reflected in projected budgetary allocations. As in many other high burden settings, macro-level drivers of TB are widely recognized. Nonetheless, while micro-level (biomedical and clinical) measures, such as improving diagnostic procedures and investment in more efficacious drugs, are being (and well should be) implemented, our findings showed that macro-level drivers of TB are underrepresented in budgeting allocations for initiatives to combat this disease. Although it could be argued that structural drivers that undermine health-promoting actions are beyond the purview of the health sector itself, we argue that strategic plans to combat TB in high burden settings need more attention to directly considering such drivers to prompt the necessary changes and reduce the burden of this and other such diseases.
Sections du résumé
BACKGROUND
Notwithstanding extensive general discussion of the effects of upstream forces on health, there has been limited empirical examination, let alone systematic evidence documenting policy responses to such pathways in the area of tuberculosis (TB) management and control. Our study aimed to gain insight into how macro level drivers of TB are perceived by key stakeholders involved in TB management and control in a high-endemic country, and to assess how such concerns are being addressed in policy initiatives in this setting. South Africa was chosen for this case study due to our team's long-standing collaborations there, its very high burden of TB, and its introduction of a strategic plan to combat this disease.
METHOD
Semi-structured interviews were conducted with 20 key informants who were purposively selected for their knowledge and expertise of TB in South Africa. South Africa's National Strategic Plan for HIV, TB and STIs 2017-2022 was then reviewed to examine how identified themes from the interviews were reflected in this policy document.
RESULTS
A history of colonization, the migrant labour system, economic inequality, poor shelter, health system challenges including TB governance, the HIV epidemic, and pertinent socio-cultural factors were all perceived to be major drivers of the epidemic. Although South Africa's current National Strategic Plan makes a firm discursive commitment to addressing the structural or macro-level drivers of TB, our analysis revealed that this commitment was not clearly reflected in projected budgetary allocations.
CONCLUSION
As in many other high burden settings, macro-level drivers of TB are widely recognized. Nonetheless, while micro-level (biomedical and clinical) measures, such as improving diagnostic procedures and investment in more efficacious drugs, are being (and well should be) implemented, our findings showed that macro-level drivers of TB are underrepresented in budgeting allocations for initiatives to combat this disease. Although it could be argued that structural drivers that undermine health-promoting actions are beyond the purview of the health sector itself, we argue that strategic plans to combat TB in high burden settings need more attention to directly considering such drivers to prompt the necessary changes and reduce the burden of this and other such diseases.
Identifiants
pubmed: 33430902
doi: 10.1186/s12992-020-00657-1
pii: 10.1186/s12992-020-00657-1
pmc: PMC7802197
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11Subventions
Organisme : Canadian Institute of Health Research
ID : ROH-115212
Références
Int J Tuberc Lung Dis. 2011 Jun;15 Suppl 2:30-36
pubmed: 21740657
Int J Tuberc Lung Dis. 2019 Jan 1;23(1):45-51
pubmed: 30572982
S Afr Med J. 2011 Feb;101(2):111-4
pubmed: 21678737
PLoS One. 2015 Mar 25;10(3):e0119861
pubmed: 25806955
Fam Pract. 1996 Feb;13(1):92-7
pubmed: 8671109
Glob Health Action. 2014 May 02;7:23594
pubmed: 24802561
Public Health Rep. 2010 Jul-Aug;125 Suppl 4:34-42
pubmed: 20626191
Lancet. 2009 Sep 12;374(9693):921-33
pubmed: 19709731
Int J Equity Health. 2011 Nov 10;10:48
pubmed: 22074349
Lancet. 2009 Sep 5;374(9692):817-34
pubmed: 19709728
Int J Tuberc Lung Dis. 2002 Dec;6(12):1075-82
pubmed: 12546115
Saf Health Work. 2018 Jun;9(2):172-179
pubmed: 29928531
Lancet Glob Health. 2019 Feb;7(2):e167-e168
pubmed: 30584051
Int J Health Serv. 2013;43(4):639-49
pubmed: 24397231
Lancet. 2015 May 2;385(9979):1799-1801
pubmed: 25814376
Global Health. 2016 Mar 31;12:10
pubmed: 27036516
BMC Infect Dis. 2016 Jun 21;16:307
pubmed: 27329161
PLoS Med. 2006 Oct;3(10):e449
pubmed: 17076568
Am J Ind Med. 2012 Jun;55(6):560-9
pubmed: 22431163
N Engl J Med. 2014 Oct 2;371(14):1344-53
pubmed: 25265493
Lancet Glob Health. 2018 May;6(5):e514-e522
pubmed: 29580761
Trans R Soc Trop Med Hyg. 2016 Mar;110(3):148-50
pubmed: 26884490
Int J Occup Environ Health. 2009 Oct-Dec;15(4):360-9
pubmed: 19886346
PLoS Med. 2019 Apr 30;16(4):e1002788
pubmed: 31039158
Glob Health Action. 2016 Jun 23;9:30528
pubmed: 27341793
Am J Public Health. 2011 Mar;101(3):524-30
pubmed: 20516372
Lancet Glob Health. 2015 Feb;3(2):e71-2
pubmed: 25617195
Am J Ind Med. 2008 Sep;51(9):640-7
pubmed: 18566985
Lancet Glob Health. 2019 Feb;7(2):e219-e226
pubmed: 30584050
BMC Med Inform Decis Mak. 2012 Aug 06;12:84
pubmed: 22867054
Soc Sci Med. 2017 Feb;174:220-227
pubmed: 28087084
Global Health. 2018 Jun 28;14(1):60
pubmed: 29954399
Int J Tuberc Lung Dis. 2018 Jun 1;22(6):606-613
pubmed: 29862943
Soc Sci Med. 2009 Jun;68(12):2240-6
pubmed: 19394122
New Solut. 2016 Feb;25(4):451-68
pubmed: 26463260
Int J Health Serv. 2013;43(4):651-64
pubmed: 24397232
Res Nurs Health. 1997 Feb;20(1):81-92
pubmed: 9024480